Nucleolar stress in diamond blackfan anemia pathophysiology

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 6, 2014, Pages 765-768

  Ellis, Steven R ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Anemia; Haploinsufficiency; Nucleolar stress; Ribosomopathy

Indexed keywords

PROTEIN MDM2; PROTEIN P53; RIBOSOME PROTEIN; RNA 5S; MDM2 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

BLACKFAN DIAMOND ANEMIA; CALCIFYING CHONDRODYSTROPHY; CARTILAGE HAIR HYPOPLASIA; CELL STRESS; CLINICAL FEATURE; DYSKERATOSIS CONGENITA; HUMAN; NONHUMAN; NUCLEOLUS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RIBOSOME; SHWACHMAN SYNDROME; SIGNAL TRANSDUCTION; ANEMIA, DIAMOND-BLACKFAN; ERYTHROCYTE; GENETICS; METABOLISM; MUTATION; PATHOLOGY; PATHOPHYSIOLOGY; TRANSCRIPTION INITIATION;

ANEMIA, DIAMOND-BLACKFAN; ERYTHROCYTES; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; RIBOSOMES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897057762     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.12.013     Document Type: Review

References (51)

1. Lipton J.M., Ellis S.R. Diamond-Blackfan anemia: diagnosis, treatment, and molecular pathogenesis. Hematol. Oncol. Clin. North Am. 2009, 23:261-282.
2. Vlachos A., Rosenberg P.S., Atsidaftos E., Alter B.P., Lipton J.M. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012, 119:3815-3819.
3. Landowski M., O'Donohue M.F., Buros C., Ghazvinian R., Montel-Lehry N., Vlachos A., Sieff C.A., Newburger P.E., Niewiadomska E., Matysiak M., Glader B., Atsidaftos E., Lipton J.M., Beggs A.H., Gleizes P.E., Gazda H.T. Novel deletion of RPL15 identified by array-comparative genomic hybridization in Diamond-Blackfan anemia. Hum. Genet. 2013, 132:1265-1274.
4. Sankaran V.G., Ghazvinian R., Do R., Thiru P., Vergilio J.A., Beggs A.H., Sieff C.A., Orkin S.H., Nathan D.G., Lander E.S., Gazda H.T. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J. Clin. Invest. 2012, 122:2439-2443.
5. Farrar J.E., Nater M., Caywood E., McDevitt M.A., Kowalski J., Takemoto C.M., Talbot C.C., Meltzer P., Esposito D., Beggs A.H., Schneider H.E., Grabowska A., Ball S.E., Niewiadomska E., Sieff C.A., Vlachos A., Atsidaftos E., Ellis S.R., Lipton J.M., Gazda H.T., Arceci R.J. Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood 2008, 112:1582-1592.
6. Flygare J., Aspesi A., Bailey J.C., Miyake K., Caffrey J.M., Karlsson S., Ellis S.R. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 2007, 109:980-986.
7. O'Donohue M.F., Choesmel V., Faubladier M., Fichant G., Gleizes P.E. Functional dichotomy of ribosomal proteins during the synthesis of mammalian 40S ribosomal subunits. J. Cell Biol. 2010, 190:853-866.
8. Ebert B.L. Molecular dissection of the 5q deletion in myelodysplastic syndrome. Semin. Oncol. 2011, 38:621-626.
9. - syndrome gene by RNA interference screen. Nature 2008, 451:335-339.
10. Perdahl E.B., Naprstek B.L., Wallace W.C., Lipton J.M. Erythroid failure in Diamond-Blackfan anemia is characterized by apoptosis. Blood 1994, 83:645-650.
11. Jaako P., Flygare J., Olsson K., Quere R., Ehinger M., Henson A., Ellis S., Schambach A., Baum C., Richter J., Larsson J., Bryder D., Karlsson S. Mice with ribosomal protein S19 deficiency develop bone marrow failure and symptoms like patients with Diamond-Blackfan anemia. Blood 2011, 118:6087-6096.
12. Danilova N., Sakamoto K.M., Lin S. Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008, 112:5228-5237.
13. Dutt S., Narla A., Lin K., Mullally A., Abayasekara N., Megerdichian C., Wilson F.H., Currie T., Khanna-Gupta A., Berliner N., Kutok J.L., Ebert B.L. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood 2011, 117:2567-2576.
14. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G.F., Bernardi R., Pandolfi P.P., Thomas G. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 2009, 11:501-508.
15. McGowan K.A., Pang W.W., Bhardwaj R., Perez M.G., Pluvinage J.V., Glader B.E., Malek R., Mendrysa S.M., Weissman I.L., Park C.Y., Barsh G.S. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 2011, 118:3622-3633.
16. Held W.A., Ballou B., Mizushima S., Nomura M. Assembly mapping of 30 S ribosomal proteins from Escherichia coli. Further studies. J. Biol. Chem. 1974, 249:3103-3111.
17. Houseley J., Tollervey D. The many pathways of RNA degradation. Cell 2009, 136:763-776.
18. Lam Y.W., Lamond A.I., Mann M., Andersen J.S. Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr. Biol. 2007, 17:749-760.
19. Nag S., Qin J., Srivenugopal K.S., Wang M., Zhang R. The MDM2-p53 pathway revisited. J. Biomed. Res. 2013, 27:254-271.
20. Zhang Y., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.
21. Zhou X., Hao Q., Liao J., Zhang Q., Lu H. Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene 2013, 32:388-396.
22. Fumagalli S., Ivanenkov V.V., Teng T., Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev. 2012, 26:1028-1040.
23. Donati G., Peddigari S., Mercer C.A., Thomas G. 5S ribosomal RNA is an essential component of a nascent ribosomal precursor complex that regulates the Hdm2-p53 checkpoint. Cell Rep. 2013, 4:87-98.
24. Venema J., Tollervey D. Ribosome synthesis in Saccharomyces cerevisiae. Annu. Rev. Genet. 1999, 33:261-311.
25. Ellis S.R., Gleizes P.E. Diamond Blackfan anemia: ribosomal proteins going rogue. Semin. Hematol. 2011, 48:89-96.
26. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., Ball S.E., Niewiadomska E., Matysiak M., Zaucha J.M., Glader B., Niemeyer C., Meerpohl J.J., Atsidaftos E., Lipton J.M., Gleizes P.E., Beggs A.H. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 2008, 83:769-780.
27. Da Costa L., Chanoz-Poulard G., Simansour M., French M., Bouvier R., Prieur F., Couque N., Delezoide A.L., Leblanc T., Mohandas N., Touraine R. First de novo mutation in RPS19 gene as the cause of hydrops fetalis in Diamond-Blackfan anemia. Am. J. Hematol. 2013, 88:340-341.
28. Abbas H.A., Maccio D.R., Coskun S., Jackson J.G., Hazen A.L., Sills T.M., You M.J., Hirschi K.K., Lozano G. MDM2 is required for survival of hematopoietic stem cells/progenitors via dampening of ROS-induced p53 activity. Cell Stem Cell 2010, 7:606-617.
29. Abbas H.A., Pant V., Lozano G. The ups and downs of p53 regulation in hematopoietic stem cells. Cell Cycle 2011, 10:3257-3262.
30. Keel S.B., Doty R.T., Yang Z., Quigley J.G., Chen J., Knoblaugh S., Kingsley P.D., De Domenico I., Vaughn M.B., Kaplan J., Palis J., Abkowitz J.L. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008, 319:825-828.
31. Quigley J.G., Gazda H., Yang Z., Ball S., Sieff C.A., Abkowitz J.L. Investigation of a putative role for FLVCR, a cytoplasmic heme exporter, in Diamond-Blackfan anemia. Blood Cells Mol. Dis. 2005, 35:189-192.
32. Rey M.A., Duffy S.P., Brown J.K., Kennedy J.A., Dick J.E., Dror Y., Tailor C.S. Enhanced alternative splicing of the FLVCR1 gene in Diamond Blackfan anemia disrupts FLVCR1 expression and function that are critical for erythropoiesis. Haematologica 2008, 93:1617-1626.
33. Belcher J.D., Beckman J.D., Balla G., Balla J., Vercellotti G. Heme degradation and vascular injury. Antioxid. Redox Signal. 2010, 12:233-248.
34. Vlachos A., Ball S., Dahl N., Alter B.P., Sheth S., Ramenghi U., Meerpohl J., Karlsson S., Liu J.M., Leblanc T., Paley C., Kang E.M., Leder E.J., Atsidaftos E., Shimamura A., Bessler M., Glader B., Lipton J.M. Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference. Br. J. Haematol. 2008, 142:859-876.
35. Liu J.M., Ellis S.R. Ribosomes and marrow failure: coincidental association or molecular paradigm?. Blood 2006, 107:4583-4588.
36. Kirwan M., Dokal I. Dyskeratosis congenita: a genetic disorder of many faces. Clin. Genet. 2008, 73:103-112.
37. Sloan K.E., Mattijssen S., Lebaron S., Tollervey D., Pruijn G.J., Watkins N.J. Both endonucleolytic and exonucleolytic cleavage mediate ITS1 removal during human ribosomal RNA processing. J. Cell Biol. 2013, 200:577-588.
38. Thiel C.T., Rauch A. The molecular basis of the cartilage-hair hypoplasia-anauxetic dysplasia spectrum. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25:131-142.
39. Wong C.C., Traynor D., Basse N., Kay R.R., Warren A.J. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011, 118:4305-4312.
40. Finch A.J., Hilcenko C., Basse N., Drynan L.F., Goyenechea B., Menne T.F., Gonzalez Fernandez A., Simpson P., D'Santos C.S., Arends M.J., Donadieu J., Bellanne-Chantelot C., Costanzo M., Boone C., McKenzie A.N., Freund S.M., Warren A.J. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011, 25:917-929.
41. Moore J.B., Farrar J.E., Arceci R.J., Liu J.M., Ellis S.R. Distinct ribosome maturation defects in yeast models of Diamond-Blackfan anemia and Shwachman-Diamond syndrome. Haematologica 2010, 95:57-64.
42. Freed E.F., Prieto J.L., McCann K.L., McStay B., Baserga S.J. NOL11, implicated in the pathogenesis of North American Indian childhood cirrhosis, is required for pre-rRNA transcription and processing. PLoS Genet. 2012, 8:e1002892.
43. Meyer B., Wurm J.P., Kotter P., Leisegang M.S., Schilling V., Buchhaupt M., Held M., Bahr U., Karas M., Heckel A., Bohnsack M.T., Wohnert J., Entian K.D. The Bowen-Conradi syndrome protein Nep1 (Emg1) has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the methylation of Psi1191 in yeast 18S rRNA. Nucleic Acids Res. 2011, 39:1526-1537.
44. Nousbeck J., Spiegel R., Ishida-Yamamoto A., Indelman M., Shani-Adir A., Adir N., Lipkin E., Bercovici S., Geiger D., van Steensel M.A., Steijlen P.M., Bergman R., Bindereif A., Choder M., Shalev S., Sprecher E. Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am. J. Hum. Genet. 2008, 82:1114-1121.
45. van Gijn D.R., Tucker A.S., Cobourne M.T. Craniofacial development: current concepts in the molecular basis of Treacher Collins syndrome. Br. J. Oral Maxillofac. Surg. 2013, 51:384-388.
46. Trainor P.A., Dixon J., Dixon M.J. Treacher Collins syndrome: etiology, pathogenesis and prevention. Eur. J. Hum. Genet. 2009, 17:275-283.
47. Gonzales B., Henning D., So R.B., Dixon J., Dixon M.J., Valdez B.C. The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum. Mol. Genet. 2005, 14:2035-2043.
48. Dauwerse J.G., Dixon J., Seland S., Ruivenkamp C.A., van Haeringen A., Hoefsloot L.H., Peters D.J., Boers A.C., Daumer-Haas C., Maiwald R., Zweier C., Kerr B., Cobo A.M., Toral J.F., Hoogeboom A.J., Lohmann D.R., Hehr U., Dixon M.J., Breuning M.H., Wieczorek D. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat. Genet. 2011, 43:20-22.
49. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., Glynn E.F., Ellington L., Du C., Dixon J., Dixon M.J., Trainor P.A. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 2008, 14:125-133.
50. Donati G., Bertoni S., Brighenti E., Vici M., Trere D., Volarevic S., Montanaro L., Derenzini M. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene 2011, 30:3274-3288.
51. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J. Biol. Chem. 2004, 279:44475-44482.